A GBT021601 ADME Microtracer Study in Healthy Volunteers

Clinical trial NCT05718687 · COMPLETED

Trial details

NCT number: NCT05718687
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2022-12-22
Primary completion: 2023-08-10
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.